Probable medication-overuse headache: The effect of a 2-month drug-free period

Neurology

Volumn 66, Issue 12, 2006, Pages 1894-1898

  Zeeberg, Peter ^a   Olesen, Jes ^a   Jensen, Rigmor ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; CODEINE; DIAZEPAM; ERGOT ALKALOID; ERGOTAMINE; LEVOMEPROMAZINE; METOCLOPRAMIDE; MORPHINE; OPIATE; PARACETAMOL; PROMETHAZINE; SUMATRIPTAN; TRANQUILIZER; TRIPTAN DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; DRUG INDUCED HEADACHE; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PRIORITY JOURNAL; SEX RATIO; STATISTICAL SIGNIFICANCE; TENSION HEADACHE; TREATMENT WITHDRAWAL; WITHDRAWAL SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CHRONIC DISEASE; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MIGRAINE DISORDERS; RISK ASSESSMENT; TREATMENT OUTCOME; WITHHOLDING TREATMENT;

EID: 33745929902     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000217914.30994.bd     Document Type: Article

References (15)

1. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 2004;24(suppl 1):9-160.
2. Silberstein S, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders. 2nd ed. (ICHD-II). Revision of criteria for 8.2 medication-overuse headache. Cephalalgia 2005;25:460-465.
3. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002;59:1011-1014.
4. Zeeberg P, Olesen J, Jensen R. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 2005;25:1159-1167.
5. Krymchantowski AV. Overuse of symptomatic medications among chronic (transformed) migraine patients: profile of drug consumption. Ar Qneuropsiquiatr 2003;61:43-47.
6. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache 1990;30:634-638.
7. Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000;20:658-662.
8. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996;36: 14-19.
9. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 2004; 24:483-490.
10. Russell MB, Rasmussen BK, Brennum J, Iversen HK, Jensen RA, Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia 1992;12:369-374.
11. Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for Controlled Trials of Drugs in Migraine. 2nd ed. Cephalalgia 2000;20:765-786.
12. Schoenen J. Guidelines for Trials of Drug Treatments in Tension-Type Headache. 1st ed. International Headache Society Committee on Clinical Trials. Cephalalgia 1995;15:165-179.
13. Lake AE 3rd, Saper JR. Chronic headache: new advances in treatment strategies. Neurology 2002;59(suppl 2):S8-S13.
14. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996;61:285-290.
15. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004;62:1706-1711.